Inhibition of BCR-ABL kinase causes inactivation of the PI3K-AKT, the JAK-STAT, and the RAS-ERK pathways to trigger apoptosis in CML cells [42]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.